Antares Pharma CEO Robert Apple's 2018 pay slips 7% to $3.5M
Antares Pharma reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Antares Pharma reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, four executives at Antares Pharma received on average a compensation package of $1.7M, a 23% decrease compared to previous year.
Average pay of disclosed executives at Antares Pharma
Robert F. Apple, Chief Executive Officer, received $3.5M in total, which decreased by 7% compared to 2017. 49% of Apple's compensation, or $1.7M, was in stock awards. Apple also received $331K in non-equity incentive plan, $850K in option awards, $550K in salary, as well as $14K in other compensation.
For fiscal year 2018, the median employee pay was $143,630 at Antares Pharma. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 24 to one.
Peter J. Graham, General Counsel, received a compensation package of $1.4M, which decreased by 2% compared to previous year. 38% of the compensation package, or $512K, was in stock awards.
Fred M. Powell, Chief Financial Officer, earned $1.3M in 2018, a 2% decrease compared to previous year.
James P. Tursi, Chief Medical Officer, received $490K in 2018.
Related executives
You may also like
Source: SEC filing on April 26, 2019.